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Abstract The aim of this study was to determine the antimi-
crobial effects of lemongrass essential oil (C. flexuosus) and to
determine cytotoxic effects of both test compounds on human
dermal fibroblasts. Antimicrobial susceptibility screening was
carried out using the disk diffusion method. Antimicrobial re-
sistance was observed in four of five Acinetobacter baumannii
strains with two strains confirmed as multi-drug-resistant
(MDR). All the strains tested were susceptible to both lemon-
grass and citral with zones of inhibition varying between 17 to
80 mm. The mean minimum inhibitory concentration (MIC)
and minimum bactericidal concentration (MBC) of citral
(mic—0.14 % and mbc—0.3 % v/v) was lower than that of
Lemongrass (mic—0.65 % and mbc—1.1 % v/v) determined
using the microtitre plate method. Cell viability using human
dermal fibroblasts (HDF; 106-05a) was determined following
exposure to both compounds and a control (Grapeseed oil)
using the XTT assay and the IC50 determined at 0.095 % (v/
v) for citral and 0.126 % (v/v) for lemongrass. Grapeseed oil
had no effect on cell viability. Live cell imaging was performed
using the LumaScope 500 imaging equipment and changes in
HDF cell morphology such as necrotic features and shrinkage
were observed. The ability of lemongrass essential oil (EO) and
citral to inhibit and kill MDR A. baumannii highlights its po-
tential for use in the management of drug-resistant infections;
however, in vitro cytotoxicity does suggest further tests are
needed before in vivo or ex vivo human exposure.
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Introduction
The global threat of antimicrobial resistance (AMR) and infec-
tions caused by AMR bacteria has raised the need for urgent
therapeutic discoveries and improvement of existing infection
control and antimicrobial practices. In recent years, the Gram-
negative bacteriumAcinetobacter baumannii has been identified
as a resilient and resistant pathogen (Perez et al. 2007).
Outbreaks in hospital and community settings caused by
multi-drug-resistant, extensively drug-resistant and pan-drug-
resistant A. baumannii have been reported worldwide.
According to Vila and Pachon (2011), new approaches and an-
timicrobial agents are needed for the control of A. baumannii
infections as the few existing treatments have not been success-
ful in managing infections caused by A. baumannii.
The failure of existing antibiotics in managing infections
caused by AMR organisms has increased interest in alternative
treatments. This is demonstrated by the breadth of literature
published in the area of natural antimicrobials especially the
antimicrobial effects of plant based essential oils (EOs). The
effects EOs are wide ranging and include antibacterial, antifun-
gal, antibiofilm, antiparasitic, antioxidant, antiviral, anticancer
and many other reported effects; however, the information on
bioactivity and toxicity of essential oils is not as extensively
studied. Despite this, the commercial use and applications of
EOs continues to grow, e.g. EOs are used in household
cleaning products, cosmetics, perfumery, insecticides, disinfec-
tant wipes, food and in management of infections in animals.
There are between 400 and 500 commercially produced
essential oils (Tisserand and Young 2013) and one EO with
a growing reputation is Lemongrass EO of the Cymbopogon
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species. The antimicrobial effect of whole lemongrass EO has
been shown in previous studies with a wide range of in vitro
activity including effects against AMR pathogens (Doran
et al. 2009; Warnke et al. 2009; Adukwu et al. 2012). The
strong antimicrobial activity of lemongrass has been attributed
to a high citral content (Marongiu et al. 2006; Adukwu et al.
2012; Kumar et al. 2013; Kpoviessi et al. 2014). Both lemon-
grass EO and citral are generally regarded as safe (GRAS) for
use as flavouring substances and is also an approved com-
pound for use as a food additive and for human consumption
(Food and drug Administration 2015a; 2015b).
Generally, cytotoxic activity of EOs and components on
human cell lines have been studied with a larger proportion
of these studies focusing on the effects of tea tree oil
(Söderberg et al. 1996; Lis-Balchin et al. 2000; Hammer
et al. 2006; Loughlin et al. 2008; Nielsen 2008). Kpoviessi
et al. (2014) investigated the cytotoxic activity of lemongrass
EO from four Cymbopogon species; C.citratus, C. giganteus,
C. nardus and C. schoenantus against a human non-cancer
diploid fibroblast cell line (W138) showing moderate toxicity
of C. citratus against this W138 cell line. The cytotoxic effect
of C. flexuosus, the EO in focus in our study and known to
possess antimicrobial activity, was not determined in the
Kpoviessi study, and the effect of the oil on dermal fibroblast
is yet to be demonstrated to our knowledge. Citral on the other
hand has been reported to cause several adverse reactions such
as sensitisation and allergic contact dermatitis (Tisserand and
Balacs 1995; Heydorn et al. 2003).
The focus of this study was to investigate the antimicrobial
activity of C. flexuosus and citral against A. baumannii and to
determine the cytotoxic activity of both C. flexuosus and citral
on human fibroblasts which is important due to the growing
usage of EOs in household applications and cosmetics as well
as proposed usage in health care applications.
Materials and methods
Bacterial strains
Five A. baumannii strains from the University of the West of
England, Bristol, UK, microbiology culture collection were
used in this study. These were ATCC® BAA-1709™ (human
isolate), ATCC® BAA-1710™ (human isolate), NCTC 12156
(ATCC 19606; type strain), ATCC 17978 (lung infection
model; human isolate) and SM 37212, a clinical isolate ob-
tained from the Pathology department at Southmead Hospital,
Bristol, UK. The strains were maintained on brain heart infu-
sion (BHI) agar (CM1136; Oxoid Ltd, Basingstoke, UK) and
sub-cultured on a weekly basis. For inoculum preparation,
single colonies were picked from a BHI agar plate into BHI
broth (CM1135; Oxoid Ltd., Basingstoke, UK) and incubated
overnight at 37 °C.
EO and component
The lemongrass EO (C. flexuosus) used in this study was
donated by Amphora Aromatics, Bristol, UK, whilst citral
(95 %; synonym—3,7-dimethyl-2,6-octadienal, geranial and
neral mixture; CAS Number 5392–40-5) was purchased from
Sigma-Aldrich, Dorset, UK. The EO and citral were stored in
a cool dark place and the containers kept tightly closed in a dry
and well-ventilated place according to the safety data
information.
Susceptibility testing
The disk diffusion assay was used to determine antimicrobial
susceptibility of the A. baumannii to a selection of antibiotics
(Table 1) using the British Society for Antimicrobial
Chemotherapy guidelines, version 13 (2014) and to whole
lemongrass EO and citral. Using the agar overlay assay, bac-
terial lawns were prepared with the inoculum size adjusted to
approximately 1.5 × 108 CFU/ml. Ten microliters of lemon-
grass EO and citral were deposited onto 6-mm filter paper
discs before placing them on the surface of Iso-sensitest agar
(Oxoid; Basingstoke, UK). The agar plates were then incubat-
ed at 37 °C for 24 h and the diameter of the zone of inhibition
(ZOI) measured in millimetres using a Vernier calliper. Each
experiment was performed in triplicate. The controls were
bacterial cultures without treatment.
Minimum inhibitory concentration and minimum
bactericidal concentration
The method used in this study for determination of inhibitory
and bactericidal activity of both lemongrass EO and citral was
similar to that use in Adukwu et al. (2012) with similar con-
centration ranges 0.03, 0.06, 0.12, 0.5, 1, 2 and 4 % (v/v), and
the only difference was the microplate reader. In this study, we
used the Tecan Infinite 200 PRO, Reading, UK for optical
density measurements. For minimum bactericidal concentra-
tion (MBC) determination, 10 μl was taken from each well
(treated and untreated) after incubation and spot inoculated on
BHI agar and incubated for 24 h at 37 °C. The concentration at




Primary cell cultures of human dermal fibroblasts (HDF; 106-
05a) were obtained from ECACC (European Collection of
Cell Cultures, Porton Down, Sailsbury, UK). HDFs were cul-
tured in DMEM (Sigma, Poole, UK, D6546) supplemented
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with 10 % (v/v) FBS (Sigma) and 1 % (v/v) GIBCO®
GlutaMAX™ (ThermoFisher Scientific, Paisley, UK). Cells
were maintained at 37 °C, in a humidified incubator at 5 %
CO2 and passagedwhen 80% confluent using 0.25%Gibco®
Trypsin-EDTA (ThermoFisher Scientific, Paisley, UK).
In vitro cytotoxicity testing
The XTT assay (X4626 SIGMA, Poole, UK) was used in
this study to assess cell viability. The HDFs were plated at
1 × 104 cells/100 μl in sterile 96-well tissue culture micro-
titre plates and incubated in a humidified atmosphere of
5 % CO2 at 37 °C for 48 h to allow the cells to reach
approximately 70 % confluence. The growth medium was
discarded and replaced with growth medium containing
serial dilutions of lemongrass EO or citral and further in-
cubated for 1 h.
Cell viability was determined using a combination of the
tetrazolium compound 2,3-Bis-(2-Methoxy-4-Nitro-5-
Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide (XTT,
Sigma) and the electron coupling reagent phenazine
methosulphate (PMS, Sigma). Each reagent was prepared sep-
arately by dissolving XTT at 1 mg/ml in pre-warmed (55 °C)
media and dissolving PMS at 1.53 mg/ml in PBS. To 1 ml of
the XTT solution, 5 μl of the PMS stock was added and then
0.25 ml of the XTT:PMS stock was added to 1-ml media to
prepare the working XTT:PMS solution.
Following incubation for 1 h with lemongrass EO or citral,
the medium containing the compounds was discarded and the
cells were washed twice with PBS before incubation with
100 μl of the working XTT:PMS solution. Cells were incu-
bated in the XTT:PMS reagent for 4 h and the absorbance read
at 490 and 690 nm on a microtitre plate reader (BMG
FLUOstar Omega). Each experiment was performed in qua-
druplicate on three separate occasions.
Controls included wells containing medium alone with-
out cells (MA) and wells containing cells treated with me-
dium alone without lemongrass EO or citral. For wave-
length correction (corrects for optical imperfections), ab-
sorbance readings at 690 nm were first subtracted from the
490-nm readings. The data set was then blank corrected
against the MA wells. The percentage viability was calcu-
lated as follows:
%viability ¼ mean absorbance of treated wells
 100=mean absorbance of cells without treatment
Data analysis and statistics
The cytotoxicity expressed as IC50 (the concentration that
caused 50 % cell death) was calculated by a four-parameter
non-linear regression using GraphPad Prism software by plot-
ting the percentage viability against the log of the oil concen-
tration. The t test was used to compare the means of both test
compounds whilst a linear regression analysis was used to
correlate the cytotoxic activity of the major component
(citral) to the lemongrass EO.
Live cell imaging
HDF cells were imaged using the LumaScope 500 (Etaluma;
Labtech, East Sussex, UK), which allows live cell imaging
within a standard incubator. A ×40 objective lens was used
under phase contrast settings. Images were acquired every
minute for 120 min.
Gas chromatography mass spectroscopy
Chemical analysis of the lemongrass and grapeseed EO was
performed using the Agilent 6890 N Gas Chromatograph sys-
tem (Agilent Technologies, USA) instrument with a HP-5
column (0.25 mm × 30 m × 0.25 μm) and an Agilent
Technologies 5973 inert MS detector with MSD. Column:
Agilent 190,915–433 capillary, 0.25 mm × 30 m × 0.25 μm.
Capillary: 30 m × 250 μm × 0.25 μm nominal. The oven
temperature program was the following: initial temperature
of 50 °C, increasing by 15 °C/min to 240 °C, and held for
30 min. The samples were dissolved in hexane, and helium
was used as the carrier gas with a 1 μl injector volume, an









Ciprofloxacin 1 18.30 (R) 17.6 (R) 0.00 (R) 30.10 (S) 0.00 (R)
Gentamicin 10 20.70 (S) 19.6 (R) 7.42 (R) 31.70 (S) 7.10 (R)
Meropenem 10 26.50 (S) 27.7 (R) 21.00 (R) 36.80 (S) 25.70 (S)
Piperacillin/Tazobactam 75/10 24.50 (S) 25.00 (S) 18.90 (R) 86.00 (S) 20.00 (I)
Criteria for defining MDR, XDR and PDR in Acinetobacter spp. (Magiorakos et al. 2012); MDR: non-susceptible to ≥1 agent in ≥3 antimicrobial
categories; XDR: non-susceptible to ≥1 agent in all but ≤2 categories; PDR: non-susceptible to all antimicrobial agents listed
(R) resistant, (S) sensitive, (I) intermediate
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injector temperature of 300 °C and a split ratio 20:1. The
injector and detector temperature were held at 280 °C. The
resulting compounds were identified by comparing retention
times and mass spectra with those of standards or their reten-
tion indices (RI) with published data and their mass spectra
with the National Institute of Standards and Technology
(NIST) library.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism 6.
Significance levels were set at P = 0.05. Where the means
of two samples were compared, the two-tailed t test was
used and where the mean from more than two samples were




The A. baumannii isolates were screened for antimicrobial
susceptibility following exposure to antibiotics from four dif-
ferent antibiotic groups. The results showed that the ATCC®
BAA-1709™ was the most sensitive of the isolates, followed
by the NCTC 12156 (ATCC 19606), the ATCC® BAA-
1710™, ATCC 17978 and the SM 37212 in that order. The
ATCC 17978 was resistant to three of the four antibiotics and
was only sensitive to the Piperacillin/Tazobactam combina-
tion whilst the SM 32712 was resistant to all the antibiotics
tested Ciprofloxacin (Quinolones), Gentamicin (aminoglyco-
sides), Meropenem (Carbapenem) and Piperacillin/
Tazobactam (Beta-lactam/beta-lactamase inhibitor). Both the
ATCC 17978 and the SM 37212 fit the criteria for MDR, i.e.
non-susceptibility to ≥1 agent and in ≥3 antimicrobial catego-
ries (Magiorakos et al. 2012).
Disk diffusion assay results showed similar activity be-
tween whole lemongrass EO and citral (Fig. 1) although the
activity of citral was slightly higher than that of whole lemon-
grass EO for three of the A. baumannii isolates (NCTC 12156,
ATCC 17978 and SM 37212). The effect of both test com-
pounds was significantly greater against the human isolate
ATCC® BAA-1709™ (P = 0.02). This isolate was the most
susceptible to the effects of the EO with full clearance of this
organism on the agar plates following incubation, i.e.
ZOI ≥ 86 mm. The other isolates demonstrated reduced sus-
ceptibility to both whole lemongrass EO and citral with inhi-
bition zones between 15 and 28 mm for lemongrass EO and
between approximately 22 and 27 mm for citral for the other
tested strains.
The inhibitory and bactericidal activity of the EO and citral
were determined using the broth micro dilution assay
(Table 2). The minimum inhibitory concentration (MIC) for
lemongrass was observed at a range between 0.25 and 1 % (v/
v) whilst that for citral was between 0.06 and 0.25% (v/v). The
observed MIC was at a lower concentration when the organ-
isms were exposed to citral then when exposed to the whole
lemongrass EO. The MBC for lemongrass EO was between
0.5 and 2 % (v/v) for lemongrass EO and between 0.25 and
0.5 % (v/v) for citral. The highest combined MIC/MBC (least
susceptible) was observed with the ATCC 1710 strain with
MIC at 1 % (v/v) and MBC 2 % (v/v) when exposed to lem-
ongrass EO although this was different with citral with the
combined MIC/MBC of the least susceptible stain (NCTC
12156) at 0.25 % (v/v) and 0.5 % (v/v) for MIC and MBC,
respectively (Table 2).
In all strains, the MIC determined following exposure to
citral was lower than that for the whole lemongrass EO and
with the exception of the NCTC 12156 strain with theMBC at
0.5% (v/v), theMBC for the four other strains were lower than
that of the lemongrass EO (Table 2).
Cytotoxic activity
XTT assay
Following exposure of the HDF cells to varying concentra-
tions of lemongrass EO, cell viability was maintained between
80 and 100 % at 0.06 % (v/v) and the lower dilutions (Fig. 2).
At 0.125 % (v/v), cell viability was approximately 60% and at
2× the concentration, i.e. 0.25 % (v/v) the cell viability was
approximately 25 %. At the tested concentrations higher than
0.25 % (v/v), exposure to lemongrass EO reduced the viability
of the HDF cells to approximately 5 %.
When the HDF cells were exposed to citral at the same
concentration ranges as the lemongrass EO, at the lowest con-
centrations between 0.008 and 0.016 % (v/v), there was no
effect on cell viability. At 0.03 % (v/v), the cell viability was
maintained between 80 and 100 %; however, at 0.06 % (v/v)
the cell viability was approximately 75 %. At 0.125 % (v/v),
the cell viability was reduced to approximately 42 %. At the
higher concentrations ≥0.25 % (v/v), no viable cells were ob-
served (Fig. 2).
The IC50 value obtained for lemongrass EO with the HDF
was approximately 0.13 % (v/v) which was slightly higher
than the IC50 of citral at approximately 0.1 % (v/v) (Table 1).
Using two-tailed t test (two-tailed), the means of both lemon-
grass EO and citral EO were compared and the difference was
not significant (P = 0.8254; R2 = 0.003132). Grapeseed oil
(the carrier oil) had no cytotoxic effects on the dermal fibro-
blasts and was therefore statistically different to the effects of
both Lemongrass EO and citral (one way ANOVA;
P = 0.0107; R2 = 0.3147).
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Live imaging
The HDF cells prior to exposure with lemongrass or citral are
shown in Fig. 3. When the HDF cells were exposed to lem-
ongrass EO at 1 % (v/v) or citral at 0.25 % (v/v), changes in
cell morphology were observed during the 120-min exposure.
Within 5 min of citral exposure, the HDFs showed no notice-
able changes; however, following 10 min, there was rounding
up of cells. Following 20 min, there was a noticeable increase
in the rounding up of cells and subsequent visible necrosis and
cell death within 60 min (Fig. 4). Similarly, lemongrass EO
also induced the rounding up of the cells following 10 min,
with an increase following 20 min. Necrosis and presence of
loosely attached cells was observed at 30, 60 and 120 min
(Fig. 4).
Discussion
A. baumannii has been described as AMR bacterium, and in
this study, the isolates and type strain investigated for antimi-
crobial susceptibility to antibiotics demonstrated a range of
susceptibilities to the different antibiotic groups tested
(Table. 1). In 4/5 A. baumannii tested in this study, antibiotic
resistance was identified and we observed varying resistance
characteristics based on the criteria defined by Magiorakos
et al. (2012). This included MDR in the ATCC 17978, PDR
in the clinical isolate SM 37212 and possibly XDR in the
ATCC BAA-1710™ isolate; however, further screening will
confirm if this is a MDR or an XDR isolate. Following anti-
biotic screening, the isolates were exposed to lemongrass EO
and major component (citral—approximately 90 % deter-
mined by GC-MS; Table 3) and found to be susceptible, in-
cluding the isolates identified as MDR.
We observed that the human isolate ATCC BAA-1709™
was most sensitive to the antibiotics tested in this study and
subsequently the most sensitive to the effects of both lemon-
grass EO and citral. Although it is difficult to make direct
comparisons between the activity of the antibiotics and the
EO/citral, the results suggest some similarity in level of activ-
ity between the different compounds. Other studies that have
investigated activity of EOs and antibiotics have predominant-
ly focused on the synergistic action (Rosato et al. 2007; Duarte
et al. 2012; Aleksic et al. 2014) rather than any comparisons
Table 2 Mean Inhibitory and bactericidal activity (% v/v) of whole
lemongrass EO and citral against A. baumannii and S.aureus isolates.
Each experiment was repeated in triplicate on three separate occasions
Microorganisms Lemongrass EO (C. flexuosus) Citral
A. baumannii sp. MIC MBC MIC MBC
NCTC 12156 0.5 0.5 0.25 0.5
ATCC 17978 0.25 1 0.13 0.25
SM 37212 1 1 0.13 0.25
ATCC 1709 0.5 1 0.06 0.25
ATCC 1710 1 2 0.13 0.25
Mean 0.65 1.1 0.14 0.3
S. aureus sp.a
HA-MSSA isolate 0.06 0.13 0.02 0.06
CA-MSSA (PVL + ve) 0.06 0.13 0.03 0.06
MSSA NCTC 13297 0.06 0.13 0.03 0.06
MRSA MW2 0.06 0.13 0.03 0.06
CA-MRSA (PVL + ve) 0.06 0.13 0.03 0.06
Mean 0.06 0.13 0.028 0.06
a Data for S .aureus from Adukwu (2013)





















Fig. 1 Comparison of the
inhibition zones (mm) of whole
lemongrass EO (black bars) and
citral (grey bars) against A.
baumannii isolates measured on
agar medium. **The disk
diffusion of ATCC® BAA-
1709™ is significantly different
from the other isolates (P = 0.02).
When the disk diffusion of the
other four isolates were
compared, there was no
significant difference (P = 0.25)
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between both compound types. However, there is a need for
further research into how the effects of lemongrass EO and/or
citral relate to the effect of antibiotics on drug sensitive and
resistant bacteria. The MIC and MBC results suggest that the
effect of citral is greater than that of whole lemongrass EO.
This was observed previously in Adukwu et al. (2012) where
the inhibitory and bactericidal concentrations of citral were
also lower against different isolates of S.aureus further indi-
cating that pure citral is more potent than whole lemongrass
EO against different bacteria species.
Following determination of antimicrobial activity, we
analysed the effect of the EO/citral on dermal fibroblasts.
In the study by Kpoviessi et al. (2014), the authors found
that only C. citratus demonstrated a moderately toxic activity
against the W138 cells (IC50 = 39.77 μg/ml) whilst the other
Cymbopogon species had low cytotoxicity against same fibro-
blast cells and suggested the need for further toxicity studies.
The authors also found that citral, approximately 75 % from
GC-MS analysis in their study, also demonstrated a moderate-
ly toxic activity (IC50 = 39.48 μg/ml).
In our study, following exposure of the dermal fibroblast
cells to lemongrass EO at the concentration 0.125 % (v/v), cell
viability was reduced to approximately 60%, and at 0.25 (v/v),
cell viability was reduced to approximately 25 %. At 0.125 %
(v/v), the effect of citral on cell viability was approximately
15–16 % greater than the activity of whole lemongrass EO on
the fibroblast cells, and at 0.25 % (v/v), there was total loss in
cell viability at the 1-h exposure time. There was no loss in cell
viability at ≤0.03 % for lemongrass EO although following
exposure to citral at the same concentration, there was approx-
imately a 15 % loss in cell viability. Overall, comparing the
effect of both whole lemongrass EO and citral the observation
is that the difference in cytotoxic activity at the concentrations
tested is approximately 20 % thus, suggesting that as the con-
centration is increased, the cytotoxicity of citral increases in
favour of citral.
This is not the first time that the cytotoxic effects of EO
components has been observed to be greater than the whole
oil. In Hammer et al. (2006), the components of TTO were
shown to be more cytotoxic against human cells lines in com-
parison to whole TTO. A similar response was found in the
study by Prashar et al. (2004) which showed that both linalool
and linalyl acetate (major components in lavender accounted
for approximately 85% of the oil) weremore cytotoxic than the
whole EO. In contrast, Hayes and Markovic (2002) showed
similar cytotoxic action (similar IC50 results) and no significant
difference when citral was compared with the Australian lemon
myrtle EO. This is similar to the findings in our study as there
was no significant difference between the IC50 of whole lem-
ongrass EO and citral (P = 0.8254) and although the oils are
different, the concentration of citral in our study (>89 % v/v)
fromGC-MS analysis (Table 3) was similar to the citral content























Lemongrass EO = 0.126%
Citral (95%) = 0.095%
Fig. 2 Dose-dependent
cytotoxicity calculated as the
relative cell viability (%) of whole
lemongrass EO, citral and
grapeseed EO (carrier oil) on
HDF as determined by the XTT
assay. Each experiment was
performed in quadruplicate on
four separate occasions.
Grapeseed oil was also performed
in quadruplicate and repeated on
two separate occasions
Fig. 3 Human dermal fibroblasts (HDF; 106-05a) obtained from
ECACC grown to 80 % confluence using the DMEM medium and
supplemented with 10 % (v/v) FBS and 1 % (v/v) Gibco®
GlutaMAX™ prior to treatment with test compounds. ×40 objective
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Recommendations by the Nomenclature Committee on
Cell Death (NCCD) are that at least two distinct methods of
assessments should be used for cell death analysis (Kroemer
et al. 2009), and in a follow-up paper by Galluzzi et al. (2009)
on guidelines for use and interpretation of cell death assays,
using methods such as enzymatic assays which involve the
incorporation of exclusive dyes and long-term survival assays
could be fundamental in answering the questions surrounding
cell death as described by the NCCD. In this study, we used
the XTT assay, now a common tool used in cell viability
assays (Berridge et al. 2005) for determining the effect of
the test compounds on cell survival and the live cell imaging
for morphological examinations of the treated HDF.
Whole Lemongrass EO (C. flexuosus) at 1% (v/v) Citral (95%, Sigma, UK) at 1% (v/v)
1 minute 1 minute
10 minutes 10 minutes
30 minutes 30 minutes
60 minutes 60 minutes
Fig. 4 Cellular morphology
changes of the HDF cells exposed
to Lemongrass EO (C. flexuosus)
at 1 % (v/v) and citral at 0.25 %
(v/v) over a 2-h period. The
images shown represent images
captured at 1, 10, 30 and 60 min,
respectively, using the
LumaScope 500. ×40 objective
Table 3 GC-MSAnalysis of lemon grass and Grapeseed EOs showing
major components









Percentage of total 100 100
a Neral and Geranial are isomers of citral hence when combined approx-
imately 89 % in this study
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Morphological examinations of the treated HDF showed
that both lemongrass EO (1 % v/v) and citral (0.25 % v/v)
caused damage to the fibroblasts within the first few minutes
and total cell death within the 120-min exposure time at the
tested concentrations. Close examination of the fibroblasts
treated by lemongrass EO showed possible cell damage with
features such as rounding up of the cells, cell shrinkage and
retraction of the pseudopods suggesting damage as a result of
apoptosis. The citral-treated fibroblasts showed an increased
amount of blebbing (spherical membrane protrusions), cell
retraction and shrinkage suggesting apoptosis as well as ne-
crotic features on the damaged fibroblasts (Leverrier and
Ridley 2001; Charras and Paluch 2008). The morphological
changes and damage observed at the tested concentrations
support the cell viability results which suggest lack of meta-
bolic activity linked to the inhibition of cell proliferation thus
cell damage and cell death features. To support the morpho-
logical observations, future studies would benefit from assess-
ments to determine apoptotic and/or necrotic activity such as
caspase activation and nuclear fragmentation assays as recom-
mended by the NCCD (Kroemer et al. 2009) Also, further
tests on cytotoxicity using this species of lemongrass in vitro
and in vivo is needed on different cell lines before deciding
whether or not to use this EO for management of human
topical infections.
In summary, we have shown that lemongrass EO and citral
were effective at inhibiting and killing MDR A. baumannii.
This enhances the potential of the lemongrass EOs as a pos-
sible alternative to antibiotics owing to its ability to effectively
inhibit and kill both MDR Gram-positive and Gram-negative
bacteria. Our study also demonstrate that at concentrations
shown to be bactericidal against Gram-negative drug-resistant
A. baumannii, whole lemongrass EO and citral act against
dermal fibroblast cells in vitro. However, at concentrations
where citral and whole lemongrass EOwere previously shown
to be inhibitory and bactericidal against drug-resistant MRSA
and MSSA (Adukwu 2013, PhD thesis), cell viability of the
HDF cells remain high (≥70 %) which is a positive finding as
it offers the potential for of these use in managing contamina-
tion in both clinical and non-clinical settings where drug-
resistant staphylococcal infections remains a major problem
globally.
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